Earnings History Data for Eagle Pharmaceuticals, Inc. (EGRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2022	PM	6:50 AM ET (Nov 7)	EGRX	Eagle Pharmaceuticals, Inc.	411.56	-0.27	0.23	-0.43	Eagle Pharmaceuticals Non-GAAP EPS of $1.12 beats by $0.21, revenue of $65.9M beats by $3.82M [11/7/2022 6:56 AM]	39.88	8.33 (26.40%)	31.55	0.0 (0.00%)	24.35 - 56.43	240,782	150,000	9,651
Eagle Pharmaceuticals Non-GAAP EPS of $1.12 beats by $0.21, revenue of $65.9M beats by $3.82M [11/7/2022 6:56 AM]
09-08-2022	PM	6:50 AM ET (Aug 9)	EGRX	Eagle Pharmaceuticals, Inc.	531.76	-0.74	2.48	0.27	Eagle Pharmaceuticals Non-GAAP EPS of $1.56 misses by $1.80, revenue of $74.1M misses by $42.79M [8/9/2022 6:52 AM]	36.30	-6.79 (-15.77%)	43.09	0.0 (0.00%)	36.17 - 58.25	172,335	120,000	4,778
Eagle Pharmaceuticals Q2 2022 Earnings Preview [8/8/2022 1:50 PM] Eagle Pharmaceuticals Non-GAAP EPS of $1.56 misses by $1.80, revenue of $74.1M misses by $42.79M [8/9/2022 6:52 AM] Is Eagle Pharmaceuticals (NASDAQ:EGRX) A Risky Investment? [Aug-08-22 11:33AM] Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript [Aug-09-22 12:00PM] Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player [Aug-09-22 08:51AM] Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Lag Estimates [Aug-09-22 08:15AM] Eagle Pharmaceuticals Reports Second Quarter 2022 Results [Aug-09-22 06:50AM] Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant [Aug-09-22 06:45AM]
09-05-2022	PM	6:50 AM ET (May 9)	EGRX	Eagle Pharmaceuticals, Inc.	554.67	3.41	3.19	-0.03	Eagle Pharmaceuticals Non-GAAP EPS of $3.41 misses by $0.25, revenue of $115.9M misses by $7.53M [5/9/2022 6:52 AM]	42.75	-0.50 (-1.16%)	43.25	0.0 (0.00%)	36.48 - 58.25	139,936	130,000	2,941
Eagle Pharmaceuticals Non-GAAP EPS of $3.41 misses by $0.25, revenue of $115.9M misses by $7.53M [5/9/2022 6:52 AM] Eagle Pharmaceuticals Reports First Quarter 2022 Results [May-09-22 06:50AM] Eagle Pharmaceuticals (EGRX) Q1 Earnings Top Estimates [May-09-22 08:25AM] Eagle Pharmaceuticals (EGRX) Q1 2022 Earnings Call Transcript [May-09-22 01:00PM]
07-03-2022	PM	6:50 AM ET (Mar 7)	EGRX	Eagle Pharmaceuticals	583.00	-0.48	0.87	0.00	Eagle Pharmaceuticals Non-GAAP EPS of $0.85 misses by $0.09, revenue of $42.32M misses by $8.76M [3/7/2022 6:52 AM]	46.38	1.28 (2.84%)	45.10	0.0 (0.00%)	36.48 - 58.25	29,317	110,000	7,034
Eagle Pharmaceuticals Non-GAAP EPS of $0.85 misses by $0.09, revenue of $42.32M misses by $8.76M [3/7/2022 6:52 AM] Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results [Mar-07-22 06:50AM] Eagle Pharmaceuticals (EGRX) Lags Q4 Earnings and Revenue Estimates [Mar-07-22 08:05AM] Eagle Pharmaceuticals (EGRX) Q4 2021 Earnings Call Transcript [Mar-07-22 12:30PM]
09-11-2021	PM	6:50 AM ET (Nov 9)	EGRX	Eagle Pharmaceuticals, Inc.	680.26	-0.43	-0.44	0.51	Eagle Pharmaceuticals EPS misses by $0.27, misses on revenue [11/9/2021 6:54 AM]	51.52	0.43 (0.84%)	51.09	0.0 (0.00%)	36.48 - 58.25	50,442	70,000	719
Eagle Pharmaceuticals Q3 2021 Earnings Preview [11/8/2021 11:52 AM] Eagle Pharmaceuticals EPS misses by $0.27, misses on revenue [11/9/2021 6:54 AM] Eagle Pharmaceuticals Reports Third Quarter 2021 Results [Nov-09-21 06:50AM] Eagle Pharmaceuticals (EGRX) Q3 Earnings and Revenues Lag Estimates [Nov-09-21 08:05AM] The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data [Nov-09-21 08:13AM] Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript [Nov-09-21 03:00PM]
09-08-2021	PM	6:50 AM ET (Aug 9)	EGRX	Eagle Pharmaceuticals, Inc.	610.03	0.27	0.21	-0.02	Eagle Pharmaceuticals EPS beats by $0.13, beats on revenue [8/9/2021 6:58 AM]	47.92	2.15 (4.70%)	45.77	0.0 (0.00%)	36.48 - 53.43	66,276	80,000	25,239
Eagle Pharmaceuticals Q2 2021 Earnings Preview [8/9/2021 4:05 AM] Eagle Pharmaceuticals EPS beats by $0.13, beats on revenue [8/9/2021 6:58 AM] Eagle Pharma in pact with AOP Orphan Pharma for heart disease therapy [8/9/2021 9:20 AM] Eagle Pharmaceuticals Reports Second Quarter 2021 Results [Aug-09-21 06:50AM] Eagle Pharmaceuticals Announces Licensing Agreement with AOP Orphan for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker [Aug-09-21 06:45AM] Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Surpass Estimates [Aug-09-21 08:05AM] Eagle Pharmaceuticals, inc (EGRX) Q2 2021 Earnings Call Transcript [Aug-09-21 04:30PM]
10-05-2021	PM	6:50 AM ET (May 10)	EGRX	Eagle Pharmaceuticals, Inc.	554.73	-0.03	0.20	0.41	Eagle Pharmaceuticals EPS misses by $0.49, misses on revenue [5/10/2021 6:51 AM]	38.39	-3.26 (-7.83%)	41.65	0.0 (0.00%)	36.48 - 56.16	79,987	90,000	1,164
Eagle Pharmaceuticals EPS misses by $0.49, misses on revenue [5/10/2021 6:51 AM] Eagle Pharmaceuticals, Inc. to Host Earnings Call [May-10-21 06:45AM] Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion ("RI") Liquid Formulation in Japan [May-10-21 06:45AM] Eagle Pharmaceuticals Reports First Quarter 2021 Results [May-10-21 06:50AM] Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss Estimates [May-10-21 08:05AM] Eagle Pharmaceuticals Inc (EGRX) Q1 2021 Earnings Call Transcript [May-10-21 11:30AM]
02-03-2021	PM	6:45 AM ET (Mar 2)	EGRX	Eagle Pharmaceuticals, Inc.	579.84	0.60	-1.42	0.18	Eagle Pharmaceuticals EPS beats by $1.16, misses on revenue [3/2/2021 6:56 AM]	40.69	-4.69 (-10.34%)	45.38	0.0 (0.00%)	33.80 - 56.16	168,043	124,979	1,406
Eagle Pharmaceuticals EPS beats by $1.16, misses on revenue [3/2/2021 6:56 AM] Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript [Mar-02-21 02:00PM]
02-11-2020	PM	6:50 AM ET (Nov 2)	EGRX	Eagle Pharmaceuticals, Inc.	600.34	0.51	0.02	-0.05	Eagle Pharmaceuticals EPS beats by $0.88, beats on revenue [11/2/2020 6:57 AM]	49.24	2.72 (5.86%)	46.52	0.0 (0.00%)	33.80 - 64.94	248,660	134,388	1,785

10-08-2020	PM	6:50 AM ET (Aug 10)	EGRX	Eagle Pharmaceuticals, Inc.	649.97	-0.02	-0.32	0.48	Eagle Pharmaceuticals EPS beats by $0.34, misses on revenue [8/10/2020 6:53 AM]	43.08	-3.92 (-8.34%)	45.07	-1.93 (-4.10%)	33.80 - 64.94	428,914	143,776	376